VERAXA Biotech (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...
BioProcess International

Transferring Your Cell Line with Confidence: Accelerating Biologics Development Through Flexible Cell Line Integration and End-to-End Support

Streamline cell line transfer with flexible process design, data-driven strategies, and real-world insights to reduce risk ...
The Manila Times

VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...
GEN

Producer Cell Lines: Large-Scale Gene Therapy Hitmakers

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...
GEN

Automation in Cell Line Development for Biotherapeutics: Current Trends and Challenges

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
Medical Xpress

Researchers identify 166 human pluripotent stem cell lines available for use in clinical applications

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...
The Manila Times

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line-Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026

TG-MVATM uses a scalable cell line manufacturing process intended to strengthen and diversify global mpox and smallpox vaccine supply ...
Detroit Free Press

Primary Cells vs. Cell Lines: Cloud-Clone Corp. Empowers Researchers to Choose the Optimal Path for Discovery

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...